Purchase Order 75N95024P00382

Award Date 8/1/24
Potential Completion Date 9/30/28
Potential Value $2.6M
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94105, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price purchase order contract awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health, to Amprion, Inc. for $1,064,800.00. The contract is for protein analysis services on 1,648 cerebrospinal fluid samples to detect the presence or absence of alpha synuclein seeds using the Amprion SYNTap assay. The contract has a period of performance of one year and does not have a set-aside designation. The contract was awarded on July 3,...
This is a firm-fixed-price purchase order award to Alamar Biosciences, Inc. by the National Institute on Aging (NIA), a civilian agency, for $247,000.00. The contract is for providing proteomic analysis services, including the NULISAseq CNS Disease Panel 120 assay, next-generation sequencing, and bioinformatic support for 1,118 plasma samples. The purpose is to identify biomarkers that can be used to classify and stage Alzheimer's disease. This award is not associated with a set-aside and is the...
This firm-fixed-price purchase order was awarded by the National Institute on Aging (NIA), a civilian federal agency, to Alamar Biosciences, Inc., a for-profit manufacturer of goods. The $92,000.00 contract is for the delivery of a "SINGLE-PLEX NULISAPCR ABSOLUTE QUANTIFICATION ASSAY OF HDGFL2 IN PLASMA SAMPLES." This contract supports the agency's research into Alzheimer's disease and central nervous system (CNS) disorders, as Alamar Biosciences specializes in providing advanced...
This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government...
The National Institutes of Health's National Institute on Aging awarded The Johns Hopkins University a $16,450.30 firm fixed price purchase order contract to provide testing and laboratory services for immunophenotyping cells in cerebrospinal fluid of Alzheimer's disease patients. The work will be performed in Baltimore, Maryland over a one year period from January 1, 2024 through December 31, 2024. This contract supports the National Institute on Aging's research efforts to better understand...
This is a firm fixed-price delivery order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Scantox Neuro GMBH, a for-profit organization based in Austria. The contract, valued at $858,106.08, is for the experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. This work supports ongoing NIA research initiatives such as the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and PREVENT-AD studies....
This is a firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Alamar Biosciences, Inc. for the ALAMAR NULISASEQ INFLAMMATION PANEL 250 REAGENTS. The contract has a ceiling value of $324,000.00 and a period of performance through July 7, 2025. Alamar Biosciences, Inc. is a for-profit manufacturer of specialized biomedical research tools and services, with a focus on diagnostic technologies for central nervous system disorders like...
This firm fixed-price purchase order awards Psomagen Inc. $422,000 to provide RNA sequencing services to the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), from June 2021 through June 2023. The contract supports NIA research on Alzheimer's disease and related dementias by requiring the contractor to construct sequencing libraries from 20 human samples, perform sequencing on an Illumina NovaSeq 6000 platform, and deliver various data files. No set-aside...
This is a $14,240.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Neuroscience Associates Inc. for laboratory testing and histology work. The contract is set aside for small businesses. Neuroscience Associates Inc. is a company that specializes in mass production neurohistology services, including embedding, sectioning, staining, imaging, and analysis of brain, spinal...
This is a $199,812 firm fixed price purchase order awarded by the National Institutes of Health's (NIH) National Institute on Aging (NIA) to QPS Austria GMBH, a contract research organization. The contract is for in vivo efficacy studies of a candidate Alzheimer's treatment in a transgenic mouse model. This award is part of the NIA's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, which aims to identify FDA-approved drugs that may be repurposed as disease-modifying...

This is a $2,640,000 firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Amprion, Inc., a for-profit organization. The contract is for protein analysis services on cerebrospinal fluid samples to detect the presence or absence of alpha-synuclein aggregates, which are associated with neurodegenerative diseases like Alzheimer's and Parkinson's. This contract is not set-aside and was initially posted under a small business sources sought notice, indicating Amprion's technical capabilities in this specialized area of neurological research. The contract has a base period from August 2024 to October 2024 for 1,200 samples, with 24 optional periods from November 2024 to September 2028 for an additional 200 samples per period, potentially totaling 4,800 samples. Amprion has also received a $1,064,800 cooperative agreement grant from the National Institute of Neurological Disorders and Stroke to support the analytical validation of a biochemical test for alpha-synuclein aggregates.

Generated 2/25/25, 10:07 AM